Moelis & Company (NYSE:MC) Shares Sold by Duality Advisers LP

Duality Advisers LP lowered its stake in shares of Moelis & Company (NYSE:MC) by 84.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,568 shares of the asset manager’s stock after selling 24,967 shares during the quarter. Duality Advisers LP’s holdings in Moelis & Company were worth $256,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in Moelis & Company by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 7,787,483 shares of the asset manager’s stock worth $351,449,000 after purchasing an additional 28,446 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Moelis & Company by 0.7% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,279,209 shares of the asset manager’s stock worth $328,511,000 after buying an additional 49,291 shares during the last quarter. HighTower Advisors LLC grew its holdings in shares of Moelis & Company by 3.2% during the third quarter. HighTower Advisors LLC now owns 1,111,200 shares of the asset manager’s stock worth $50,144,000 after buying an additional 34,740 shares during the last quarter. Northern Trust Corp increased its position in Moelis & Company by 32.7% in the 3rd quarter. Northern Trust Corp now owns 927,705 shares of the asset manager’s stock valued at $41,867,000 after acquiring an additional 228,840 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in Moelis & Company by 5.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 792,729 shares of the asset manager’s stock valued at $35,776,000 after acquiring an additional 42,424 shares during the last quarter. Institutional investors and hedge funds own 91.53% of the company’s stock.

Moelis & Company Price Performance

MC opened at $49.75 on Friday. The company has a 50-day moving average of $54.07 and a 200-day moving average of $51.54. Moelis & Company has a 1-year low of $33.87 and a 1-year high of $58.67.

Moelis & Company (NYSE:MC) last posted its quarterly earnings results on Wednesday, April 24th. The asset manager reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.11. Moelis & Company had a negative return on equity of 0.13% and a negative net margin of 1.33%. The business had revenue of $217.49 million for the quarter, compared to analyst estimates of $219.30 million. During the same period in the prior year, the company posted $0.05 EPS. The business’s revenue was up 17.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Moelis & Company will post 1.47 earnings per share for the current fiscal year.

Moelis & Company Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Monday, May 6th will be paid a $0.60 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $2.40 dividend on an annualized basis and a yield of 4.82%. Moelis & Company’s payout ratio is currently -1,263.16%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on MC. StockNews.com upgraded shares of Moelis & Company from a “sell” rating to a “hold” rating in a research note on Thursday, February 8th. JPMorgan Chase & Co. boosted their target price on shares of Moelis & Company from $46.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, February 8th. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $54.00 target price (down from $58.00) on shares of Moelis & Company in a report on Thursday. JMP Securities restated a “market perform” rating on shares of Moelis & Company in a report on Tuesday, April 9th. Finally, UBS Group upped their price objective on shares of Moelis & Company from $45.00 to $47.00 and gave the company a “sell” rating in a research report on Thursday. Two research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $50.80.

Insider Activity

In other news, insider Navid Mahmoodzadegan sold 20,001 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $55.82, for a total transaction of $1,116,455.82. Following the completion of the transaction, the insider now directly owns 79,859 shares of the company’s stock, valued at $4,457,729.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Navid Mahmoodzadegan sold 20,001 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $55.82, for a total transaction of $1,116,455.82. Following the completion of the transaction, the insider now directly owns 79,859 shares of the company’s stock, valued at $4,457,729.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christopher Callesano sold 1,040 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $53.59, for a total value of $55,733.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 375,185 shares of company stock valued at $20,130,225. 6.96% of the stock is currently owned by insiders.

Moelis & Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.